The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD8683 After Single Ascending Doses in Healthy Male Subjects
- collapse A double-blind, placebo controlled, randomised, parallel group, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of AZD8848 administered intranasally once weekly over 7 weeks in mild to moderate asthma patients challenged with an inhaled allergen.
- collapse A double-blind, placebo controlled, randomized, parallel group study to investigate the tolerability, safety, pharmacodynamics and pharmacokinetics of repeated weekly doses of AZD8848 administered intranasally to seasonal allergic rhinitis patients
- collapse A Phase I, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Fostamatinib Disodium in Healthy Japanese and White Subjects After Single and Multiple Ascending Doses
- collapse An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers When Fostamatinib Disodium 150 mg is Administered Alone and in Combination With Verapamil
- collapse Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
- collapse Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
- collapse A Phase I, open label, fixed sequence, single centre study in healthy volunteers to investigate the effects of repeated oral doses AZD9668 on the pharmacokinetics and pharmacodynamics of a single dose of warfarin
- collapse An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
- collapse A randomized, multicenter, placebo and active-controlled, single-dose, 4-period, crossover study to evaluate the bronchodilating effect of SYMBICORT pMDI versus Advair Diskus and Ventolin HFA.
